News | June 04, 2024
Aurigene Pharmaceutical opens biologics facility in Genome Valley, Hyderabad
The state-of-the-art facility is equipped with best-in-class equipment and control systems
The state-of-the-art facility is equipped with best-in-class equipment and control systems
The Profit After Tax (PAT) for Q4 FY24 at Rs 36.40 crore, compared to Rs 38.23 crore in Q4 FY23
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
Subscribe To Our Newsletter & Stay Updated
